COVID-19

Coronavirus disease 2019 (COVID-19, dem sanso know am as SARS-2) be a contagious disease wey be caused by de coronavirus SARS-CoV-2. Insyd January 2020, na de disease spread worldwide, wey result in de COVID-19 pandemic.

De symptoms of COVID‑19 fi vary buh often dey include fever,Islam MA (April 2021). "Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients". PLOS ONE. 16 (4): e0249788. Bibcode:2021PLoSO..1649788I. doi:10.1371/journal.pone.0249788. PMC 8023501. PMID 33822812. fatigue, cough, breathing difficulties, loss of smell, den loss of taste.Saniasiaya J, Islam MA (April 2021). "Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients". The Laryngoscope. 131 (4): 865–878. doi:10.1002/lary.29286. ISSN 0023-852X. PMC 7753439. PMID 33219539.Saniasiaya J, Islam MA (November 2020). "Prevalence and Characteristics of Taste Disorders in Cases of COVID-19: A Meta-analysis of 29,349 Patients" (PDF). Otolaryngology–Head and Neck Surgery. 165 (1): 33–42. doi:10.1177/0194599820981018. PMID 33320033. S2CID 229174644.Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R (August 2020). "Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis". Mayo Clin. Proc. 95 (8): 1621–1631. doi:10.1016/j.mayocp.2020.05.030. PMC 7275152. PMID 32753137. Symptoms fi begin one to fourteen days after exposure to de virus. At least a third of people wey be infected no dey develop noticeable symptoms.Wang B, Andraweera P, Elliott S, Mohammed H, Lassi Z, Twigger A, et al. (March 2023). "Asymptomatic SARS-CoV-2 Infection by Age: A Global Systematic Review and Meta-analysis". The Pediatric Infectious Disease Journal. 42 (3): 232–239. doi:10.1097/INF.0000000000003791. PMC 9935239. PMID 36730054.Oran DP, Topol EJ (January 2021). "The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review". Annals of Internal Medicine. 174 (5): M20-6976. doi:10.7326/M20-6976. PMC 7839426. PMID 33481642. Of those wey develop symptoms noticeable enough make dem be classified as patients, chaw (81%) dey develop mild to moderate symptoms (up to mild pneumonia), while 14% dey develop severe symptoms (dyspnea, hypoxia, anaa more dan 50% lung involvement on imaging), den 5% dey develop critical symptoms (respiratory failure, shock, anaa multiorgan dysfunction)."Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)". U.S. Centers for Disease Control and Prevention (CDC). 6 April 2020. Archived from the original on 2 March 2020. Retrieved 19 April 2020. Older people get a higher risk of dem dey develop severe symptoms. Sam complications dey result in death. Sam people continue dey experience a range of effects (long COVID) for months anaa years after infection, wey na dem observe damage.Davis HE, McCorkell L, Vogel JM, Topol EJ (March 2023). "Long COVID: major findings, mechanisms and recommendations". Nature Reviews. Microbiology. 21 (3): 133–146. doi:10.1038/s41579-022-00846-2. PMC 9839201. PMID 36639608. Multi-year studies for de long-term effects dey go on.CDC (11 February 2020). "Post-COVID Conditions". U.S. Centers for Disease Control and Prevention (CDC). Retrieved 12 July 2021.

Testing methods for COVID-19 make dem detect de virus ein nucleic acid dey include real-time reverse transcription polymerase chain reaction (RT‑PCR),"Overview of Testing for SARS-CoV-2, the virus that causes COVID-19". U.S. Centers for Disease Control and Prevention (CDC). 11 February 2020. Retrieved 31 July 2022."Nucleic Acid Amplification Tests (NAATs)". U.S. Centers for Disease Control and Prevention (CDC). 11 February 2020. Retrieved 31 July 2022. transcription-mediated amplification,Gorzalski AJ, Tian H, Laverdure C, Morzunov S, Verma SC, VanHooser S, et al. (August 2020). "High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2". Journal of Clinical Virology. 129: 104501. doi:10.1016/j.jcv.2020.104501. PMC 7286273. PMID 32619959. den reverse transcription loop-mediated isothermal amplification (RT‑LAMP) from a nasopharyngeal swab.Li C, Zhao C, Bao J, Tang B, Wang Y, Gu B (November 2020). "Laboratory diagnosis of coronavirus disease-2019 (COVID-19)". Clinica Chimica Acta; International Journal of Clinical Chemistry. 510: 35–46. doi:10.1016/j.cca.2020.06.045. PMC 7329657. PMID 32621814.

References

 Read further 

 "Progress report on the coronavirus pandemic". Nature. 584 (7821): 325. 1 August 2020. doi:10.1038/D41586-020-02414-1. ISSN 1476-4687. PMID 32814893. Wikidata Q98568681.
 COVID-19 infection prevention and control measures for primary care, including general practitioner practices, dental clinics and pharmacy settings: first update. European Centre for Disease Prevention and Control (ECDC) (Report). October 2020.
 Erola Pairo-Castineira, Sara Clohisey, Lucija Klarić, Andrew Bretherick, Konrad Rawlik, Dorota Pasko, et al. (11 December 2020). "Genetic mechanisms of critical illness in Covid-19". Nature. doi:10.1038/S41586-020-03065-Y. ISSN 1476-4687. PMID 33307546. Wikidata Q104287299. Scholia Q104287299.

 External links 

 Health agencies 
 Coronavirus disease (COVID‑19) Facts by de World Health Organization (WHO)
 Coronavirus (COVID‑19) by de UK National Health Service (NHS)
 Coronavirus 2019 (COVID-19) by de US Centers for Disease Control and Prevention (CDC)

 Directories 
 Coronavirus Resource Center at de Center for Inquiry
 COVID‑19 Information on FireMountain.net Archived 13 January 2022 at the Wayback Machine
 COVID‑19 Resource Directory on OpenMD

 Medical journals 
 BMJ's Coronavirus (covid‑19) Hub by de BMJ
 Coronavirus (Covid‑19) by The New England Journal of Medicine
 Coronavirus (COVID‑19) Research Highlights by Springer Nature
 Coronavirus Disease 2019 (COVID‑19) by JAMA
 COVID‑19 Resource Centre by The Lancet
 Covid‑19: Novel Coronavirus Archived 24 September 2020 at the Wayback Machine by Wiley Publishing
 Novel Coronavirus Information Center by Elsevier

 Treatment guidelines 

 "Bouncing Back From COVID-19: Your Guide to Restoring Movement" (PDF). Johns Hopkins Medicine.
 "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines" (PDF). National Institutes of Health.
 "Guidelines on the Treatment and Management of Patients with COVID-19". Infectious Diseases Society of America.
 "JHMI Clinical Recommendations for Available Pharmacologic Therapies for COVID-19" (PDF). Johns Hopkins Medicine.
 NHS England and NHS Improvement. National Guidance for post-COVID syndrome assessment clinics (Report).
 World Health Organization (2022). Therapeutics and COVID-19: living guideline, 14 January 2022 (Report). hdl:10665/351006. WHO/2019-nCoV/therapeutics/2022.1.


Category:Occupational safety den health
Category:Vaccine-preventable diseases
Category:Viral respiratory tract infections
Category:Zoonoses
Category:Public health
Category:Coronavirus-associated diseases
Category:Translated from MDWiki